OBQI Oncology Biomarker Quality Iniative

OMOP Observational Medical Outcomes Partnership

OSE Office of Surveillance and Epidemiology (FDA)

PDUFA Prescription Drug User Fee Act

PET positron emission tomography

PhRMA Pharmaceutical Research and Manufacturers of America

PPAR peroxisome proliferator–activated receptor

PSA prostate-specific antigen

PSTC Predictive Safety Testing Consortium

RACC reference amount customarily consumed

RCT randomized controlled trial or reverse cholesterol transport

RDI Reference Daily Intake

REMS risk evaluation and mitigation strategies

RiskMAPS risk minimization action plans

RNA ribonucleic acid

SSA significant scientific agreement

TMUGS tumor marker utility grading system

US ultrasound

USDA U.S. Department of Agriculture

VLDL very low-density lipoprotein

VXDS voluntary exploratory data submission

WHO World Health Organization

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement